CRSP (crisprtx.com) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Symbol and logo of brand crisprtx.com (CRSP)

CRISPR Therapeutics AG (CRSP) is implementing eco-friendly standards in its laboratories to optimize resources. The EV/EBITDA level over the time interval on the GURU.Markets terminal linear chart illustrates this trend, where 0.00 reflects the most recent value of the metric. Leadership in gene editing and royalties establish a foundation for FCF, while the confident management of Samarthit Chatterjee ensures liquidity during therapy commercialization.

CRSP (CRISPR) Business Value to Operating Income Before Depreciation history from 11/23/2025 to 11/17/2026

Comprehensive metric breakdowns and analytics for CRISPR Therapeutics (CRSP)

Initial company analysis:CRSP (CRISPR Therapeutics AG)
Product sample of crisprtx.com

CRISPR Therapeutics AG (CRSP) is scaling its contract manufacturing capacities and validating gene-editing boxes, which requires significant capital expenditures. By analyzing the company's EV/EBITDA multiple on the chart, an investor assesses the total enterprise value, including net debt, relative to operating profit to determine cash flow generation efficiency and capitalization stability amid fluctuating interest rates.

Key competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tempus AI TEM|qiagen.com (QGEN) - Company Value to EBITDA|IONS: Enterprise Value to EBITDA Ratio|Enterprise Value to EBITDA Multiple Repligen (RGEN)|RNA (Avidity) - Enterprise Value to EBITDA Ratio|GeneDx Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ultragenyx|Company Value to EBITDA beamtx.com BEAM|Enterprise Value to EBITDA Ratio SRPT (Sarepta Therapeutics, Inc.)|TWST - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 10x TXG|Enterprise Value to Operating Income Before Depreciation Ratio NTLA (Intellia)|Stoke Corp - EV/EBITDA Multiple|BLFS: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|WVE: EV/EBITDA Multiple|Company Value to EBITDA Maze Tx (MAZE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sionna Therapeutics|Enterprise Value to Operating Income Before Depreciation PRME (Prime Medicine Corp)|EV/EBITDA Multiple TSHA|EV/EBITDA Multiple uniqure.com (QURE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MeiraGTx PLC MGTX|Business Value to Operating Income Before Depreciation RGNX|solidbio.com - EV/EBITDA Multiple|OCGN (Ocugen Pharma) - Enterprise Value to Operating Income Before Depreciation|PACB: EV/EBITDA Multiple|Benitec Biopharma (BNTC) - EV/EBITDA Multiple|DSGN (Design Therapeutics Inc) - EV/EBITDA Multiple|Rocket Pharmaceuticals, Inc. (RCKT) - Total Company Value to Operating Income Before Depreciation Ratio|FDMT - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization LXEO (Lexeo)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization korrobio.com KRRO|Total Company Value to Operating Income Before Depreciation Ratio Editas Medicine, Inc. (EDIT)|SLN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio ProQR PRQR|CDXS: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Sangamo BioSciences SGMO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nautilus Bio|MGX (Metagenomi, Inc.) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple DTIL|Generation Bio - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BOLD (Boundless Bio Inc.)|Business Value to Operating Income Before Depreciation XCUR|Imunon Inc - EV/EBITDA Multiple|PHIO (phiopharma.com) - Enterprise Value to Operating Income Before Depreciation|MBIO (mustangbio.com) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation RNAZ|BNGO (Bionano) - EV/EBITDA Multiple|EV/EBITDA Multiple Applied DNA Corp|EV/EBITDA Multiple BLUE|EV/EBITDA Multiple ImmunoPrecise Antibodies Ltd. (IPA)|EV/EBITDA Multiple OMGA (omegatherapeutics.com)|OMIC: Enterprise Value to Operating Income Before Depreciation|RGLS: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation SYRS (Syros Pharmaceuticals, Inc)|TBIO: EV/EBITDA Multiple|TRACON Pharmaceuticals (TCON) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Unity Biotechnology, Inc